147 related articles for article (PubMed ID: 8420300)
1. Risk of disease progression in asymptomatic multiple myeloma.
Dimopoulos MA; Moulopoulos A; Smith T; Delasalle KB; Alexanian R
Am J Med; 1993 Jan; 94(1):57-61. PubMed ID: 8420300
[TBL] [Abstract][Full Text] [Related]
2. Prognostic features of asymptomatic multiple myeloma.
Weber DM; Dimopoulos MA; Moulopoulos LA; Delasalle KB; Smith T; Alexanian R
Br J Haematol; 1997 Jun; 97(4):810-4. PubMed ID: 9217181
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in low tumour mass asymptomatic multiple myeloma: a report on 91 patients. The Groupe d'Etudes et de Recherche sur le Myélome (GERM).
Facon T; Menard JF; Michaux JL; Euller-Ziegler L; Bernard JF; Grosbois B; Daragon A; Azais I; Courouble Y; Kaplan G
Am J Hematol; 1995 Feb; 48(2):71-5. PubMed ID: 7847344
[TBL] [Abstract][Full Text] [Related]
4. Prognosis of asymptomatic multiple myeloma.
Alexanian R; Barlogie B; Dixon D
Arch Intern Med; 1988 Sep; 148(9):1963-5. PubMed ID: 2458080
[TBL] [Abstract][Full Text] [Related]
5. Classification and prognostic evaluation in multiple myeloma. A retrospective study of relationship of survivals and responses to chemotherapy to immunological types, 20 single prognostic factors, 15 clinical staging systems, and 6 morphological classifications.
Pasqualetti P; Colantonio D; Collacciani A; Casale R; Natali G
Panminerva Med; 1991; 33(2):93-110. PubMed ID: 1923560
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma.
Hillengass J; Fechtner K; Weber MA; Bäuerle T; Ayyaz S; Heiss C; Hielscher T; Moehler TM; Egerer G; Neben K; Ho AD; Kauczor HU; Delorme S; Goldschmidt H
J Clin Oncol; 2010 Mar; 28(9):1606-10. PubMed ID: 20177023
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of vertebral lesions detected by magnetic resonance imaging in patients with stage I multiple myeloma.
Mariette X; Zagdanski AM; Guermazi A; Bergot C; Arnould A; Frija J; Brouet JC; Fermand JP
Br J Haematol; 1999 Mar; 104(4):723-9. PubMed ID: 10192431
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of magnetic resonance imaging in patients with asymptomatic multiple myeloma.
Moulopoulos LA; Dimopoulos MA; Smith TL; Weber DM; Delasalle KB; Libshitz HI; Alexanian R
J Clin Oncol; 1995 Jan; 13(1):251-6. PubMed ID: 7799027
[TBL] [Abstract][Full Text] [Related]
9. Localized and indolent myeloma.
Alexanian R
Blood; 1980 Sep; 56(3):521-5. PubMed ID: 7407416
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging pattern of bone marrow involvement as a new predictive parameter of disease progression in newly diagnosed patients with multiple myeloma eligible for autologous stem cell transplantation.
Song MK; Chung JS; Lee JJ; Min CK; Ahn JS; Lee SM; Shin DY; Bae SH; Hong J; Lee GW; Lee IS; Shin HJ
Br J Haematol; 2014 Jun; 165(6):777-85. PubMed ID: 24628463
[TBL] [Abstract][Full Text] [Related]
11. Bence Jones proteinuria in smoldering multiple myeloma as a predictor marker of progression to symptomatic multiple myeloma.
González-Calle V; Dávila J; Escalante F; de Coca AG; Aguilera C; López R; Bárez A; Alonso JM; Hernández R; Hernández JM; de la Fuente P; Puig N; Ocio EM; Gutiérrez NC; García-Sanz R; Mateos MV
Leukemia; 2016 Oct; 30(10):2026-2031. PubMed ID: 27133826
[TBL] [Abstract][Full Text] [Related]
12. Multiple myeloma--presenting as acute kidney injury.
Prakash J; Niwas SS; Parekh A; Vohra R; Wani IA; Sharma N; Usha
J Assoc Physicians India; 2009 Jan; 57():23-6. PubMed ID: 19753754
[TBL] [Abstract][Full Text] [Related]
13. Smoldering multiple myeloma: when to observe and when to treat?
Mateos MV; San Miguel JF
Am Soc Clin Oncol Educ Book; 2015; ():e484-92. PubMed ID: 25993213
[TBL] [Abstract][Full Text] [Related]
14. A magnetic resonance imaging-based prognostic scoring system to predict outcome in transplant-eligible patients with multiple myeloma.
Mai EK; Hielscher T; Kloth JK; Merz M; Shah S; Raab MS; Hillengass M; Wagner B; Jauch A; Hose D; Weber MA; Delorme S; Goldschmidt H; Hillengass J
Haematologica; 2015 Jun; 100(6):818-25. PubMed ID: 25795721
[TBL] [Abstract][Full Text] [Related]
15. Clinical course of light-chain smouldering multiple myeloma (idiopathic Bence Jones proteinuria): a retrospective cohort study.
Kyle RA; Larson DR; Therneau TM; Dispenzieri A; Melton LJ; Benson JT; Kumar S; Rajkumar SV
Lancet Haematol; 2014 Oct; 1(1):e28-e36. PubMed ID: 25530988
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma.
Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS
Acta Radiol; 2008 May; 49(4):427-35. PubMed ID: 18415787
[TBL] [Abstract][Full Text] [Related]
17. Solitary plasmacytoma of bone and asymptomatic multiple myeloma.
Dimopoulos MA; Moulopoulos A; Delasalle K; Alexanian R
Hematol Oncol Clin North Am; 1992 Apr; 6(2):359-69. PubMed ID: 1582978
[TBL] [Abstract][Full Text] [Related]
18. Lenalidomide plus dexamethasone versus observation in patients with high-risk smouldering multiple myeloma (QuiRedex): long-term follow-up of a randomised, controlled, phase 3 trial.
Mateos MV; Hernández MT; Giraldo P; de la Rubia J; de Arriba F; Corral LL; Rosiñol L; Paiva B; Palomera L; Bargay J; Oriol A; Prosper F; López J; Arguiñano JM; Quintana N; García JL; Bladé J; Lahuerta JJ; Miguel JS
Lancet Oncol; 2016 Aug; 17(8):1127-1136. PubMed ID: 27402145
[TBL] [Abstract][Full Text] [Related]
19. International prognostic index (IPI)--a critical comparison with five multiple myeloma staging systems in the group of 270 patients treated by conventional chemotherapy.
Scudla V; Zemanova M; Minarik J; Bacovsky J; Ordeltova M; Indrak K; Budikova M; Dusek L; Farbiakova V
Neoplasma; 2006; 53(4):277-84. PubMed ID: 16830053
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Cesana C; Klersy C; Barbarano L; Nosari AM; Crugnola M; Pungolino E; Gargantini L; Granata S; Valentini M; Morra E
J Clin Oncol; 2002 Mar; 20(6):1625-34. PubMed ID: 11896113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
